{"title":"The Silent Surge: Obesity Driving a Global Cardiovascular Crisis.","authors":"Panniyammakal Jeemon, Sivasankaran Sivasubramonian","doi":"10.5334/gh.1464","DOIUrl":null,"url":null,"abstract":"<p><p>Recent global estimates indicate that more than one billion people live with obesity, a figure that has doubled since 1990. When overweight individuals are included, nearly 2.5 billion adults are affected, with high body mass index contributing to an estimated 1.9 million cardiovascular disease (CVD) deaths annually. Obesity and its close association with CVD remain pressing public health challenges that require sustained, coordinated action. Recent global policy discussions, including the UN General Assembly's Zero Draft Political Declaration, highlight the importance of improving food labelling, taxing sugary drinks, limiting the marketing of unhealthy foods, and encouraging active living through supportive urban planning. Countries are encouraged to align national obesity strategies with the WHO's 2022 Acceleration Plan to STOP Obesity, with clear goals and mechanisms for accountability and monitoring. Preventive measures are most effective when introduced early, such as encouraging breastfeeding and creating supportive school environments that offer balanced meals, limit access to unhealthy foods, and incorporate regular physical activity into daily schedules. Fiscal measures, including taxes, subsidies, and mandatory nutrition labels, can help guide consumer choices towards healthier options. Supportive built environments with safe access to parks, pedestrian routes, and cycling paths further encourage active lifestyles. Health systems are central in ensuring equitable access to prevention and treatment, delivered through stigma-free and evidence-based care. Community-based and family-oriented programs have shown promise, while pharmacological options may complement lifestyle approaches where appropriate. Long-term progress depends on sustained commitment, cross-sectoral collaboration, and integration of obesity prevention into broader public health frameworks.</p>","PeriodicalId":56018,"journal":{"name":"Global Heart","volume":"20 1","pages":"77"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12412452/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Heart","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5334/gh.1464","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Recent global estimates indicate that more than one billion people live with obesity, a figure that has doubled since 1990. When overweight individuals are included, nearly 2.5 billion adults are affected, with high body mass index contributing to an estimated 1.9 million cardiovascular disease (CVD) deaths annually. Obesity and its close association with CVD remain pressing public health challenges that require sustained, coordinated action. Recent global policy discussions, including the UN General Assembly's Zero Draft Political Declaration, highlight the importance of improving food labelling, taxing sugary drinks, limiting the marketing of unhealthy foods, and encouraging active living through supportive urban planning. Countries are encouraged to align national obesity strategies with the WHO's 2022 Acceleration Plan to STOP Obesity, with clear goals and mechanisms for accountability and monitoring. Preventive measures are most effective when introduced early, such as encouraging breastfeeding and creating supportive school environments that offer balanced meals, limit access to unhealthy foods, and incorporate regular physical activity into daily schedules. Fiscal measures, including taxes, subsidies, and mandatory nutrition labels, can help guide consumer choices towards healthier options. Supportive built environments with safe access to parks, pedestrian routes, and cycling paths further encourage active lifestyles. Health systems are central in ensuring equitable access to prevention and treatment, delivered through stigma-free and evidence-based care. Community-based and family-oriented programs have shown promise, while pharmacological options may complement lifestyle approaches where appropriate. Long-term progress depends on sustained commitment, cross-sectoral collaboration, and integration of obesity prevention into broader public health frameworks.
Global HeartMedicine-Cardiology and Cardiovascular Medicine
CiteScore
5.70
自引率
5.40%
发文量
77
审稿时长
5 weeks
期刊介绍:
Global Heart offers a forum for dialogue and education on research, developments, trends, solutions and public health programs related to the prevention and control of cardiovascular diseases (CVDs) worldwide, with a special focus on low- and middle-income countries (LMICs). Manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent CVDs and the underlying factors. The emphasis should be on approaches applicable in settings with limited resources.
Economic evaluations of successful interventions are particularly welcome. We will also consider negative findings if important. While reports of hospital or clinic-based treatments are not excluded, particularly if they have broad implications for cost-effective disease control or prevention, we give priority to papers addressing community-based activities. We encourage submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations related to prevention.
Global Heart is particularly interested in publishing data from updated national or regional demographic health surveys, World Health Organization or Global Burden of Disease data, large clinical disease databases or registries. Systematic reviews or meta-analyses on globally relevant topics are welcome. We will also consider clinical research that has special relevance to LMICs, e.g. using validated instruments to assess health-related quality-of-life in patients from LMICs, innovative diagnostic-therapeutic applications, real-world effectiveness clinical trials, research methods (innovative methodologic papers, with emphasis on low-cost research methods or novel application of methods in low resource settings), and papers pertaining to cardiovascular health promotion and policy (quantitative evaluation of health programs.